Oncology News

Oncology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fabiani E et al. - Rhe GSTP1-105Val allele was associated to an increased risk of MDS and to higher probability of overall survival in the low/intermediate-1 IPSS risk group. The GSTP1-Ile105Val polymorphism is likely to influence MDS risk and prognosis.

Related Articles

Successful Treatment With Sumatriptan in a Case With Cyclic Vomiting Syndrome Combined With 18q– Syndrome
Journal of Child Neurology, 10/02/09    Relevance Score: 47%

Metabolic Syndrome Among College Students
The Journal for Nurse Practitioners, 11/19/09    Relevance Score: 46%

Common infectious agents prevalence in antiphospholipid syndrome
Lupus, 11/05/09    Relevance Score: 46%

A Prospective Investigation of Biomechanical Risk Factors for Patellofemoral Pain Syndrome: The Joint Undertaking to Monitor and Prevent ACL Injury (JUMP-ACL) Cohort
American Journal of Sports Medicine, 11/02/09    Relevance Score: 46%

Adult-onset Still’s disease, Schnitzler syndrome, and autoinflammatory syndromes in adulthood
Zeitschrift für Rheumatologie, 10/29/09    Relevance Score: 46%

Today in Basic Science/Genetics...keeping you current

Thrombopoietin in normal and neoplastic stem cell development
Best Practice & Research: Clinical Haematology , 12/07/09

Mechanisms of mutations in myeloproliferative neoplasms
Best Practice & Research: Clinical Haematology , 12/07/09

Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma
International Journal of Cancer, 12/07/09

Today in Myeloproliferative Dz...keeping you current

Thrombopoietin in normal and neoplastic stem cell development
Best Practice & Research: Clinical Haematology , 12/07/09

Mechanisms of mutations in myeloproliferative neoplasms
Best Practice & Research: Clinical Haematology , 12/07/09

Solitary Plasmacytoma
American Journal of Clinical Oncology, 12/07/09